C.L. Ferguson - Concepedia

Author

C.L. Ferguson

Also Known As

B Barratt, C Ferguson, C. Ferguson, C.L. Ferguson, Catherine Ferguson, Catherine L Ferguson, Catherine L. Ferguson, Linda Agyemang, Rachel Liddle

Publications

870

Citations

H-Index

Concepts

All Affiliations

Augusta University NRG Oncology The University of Texas MD Anderson Cancer Center Yonsei University Health System University of Oklahoma Health Sciences Center

About

C.L. Ferguson is an author at Augusta University specializing in oncology, radiation oncology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	118
2	Health Sciences	2	2	89
3	Radiation Medicine	1	1	50
4	Cancer Therapeutics	1	1	15
5	Gynecology Oncology	1	1	14

C.L. Ferguson

Publications

672

Citations

H-Index

Page 1

	Year	Citations
Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology–RTOG 1203 Ann H. Klopp, Anamaria R. Yeung, Snehal Deshmukh, Journal of Clinical Oncology	2018	347
Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study Anamaria R. Yeung, Stephanie L. Pugh, Ann H. Klopp, Journal of Clinical Oncology	2020	124
A Phase III Randomized Trial Comparing Patient-Reported Toxicity and Quality of Life (QOL) During Pelvic Intensity Modulated Radiation Therapy as Compared to Conventional Radiation Therapy Ann H. Klopp, Anamaria R. Yeung, S. Deshmukh, International Journal of Radiation OncologyBiologyPhysics Quality Of LifeRadiation MedicineOncologyConventional Radiation TherapyRadiation Therapy	2016	50
A retrospective quality of life analysis using the lung cancer symptom scale in patients treated with palliative radiotherapy for advanced nonsmal cell lung cancer Stephen Lutz, David Huang, C.L. Ferguson, International Journal of Radiation OncologyBiologyPhysics Palliative CareQuality Of LifeLife AssessmentLife AnalysisRetrospective Quality	1997	39
Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial Anamaria R. Yeung, Snehal Deshmukh, Ann H. Klopp, Journal of Clinical Oncology	2022	34
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment <sup>18</sup> F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non–Small Cell Lung Cancer Feng‐Ming Kong, Chen Hu, Daniel A. Pryma, Journal of Clinical Oncology	2024	29
IMRT Improves Late Toxicity Compared to Conventional RT: An Update on NRG Oncology-RTOG 1203 Anamaria R. Yeung, S. Pugh, Ann H. Klopp, International Journal of Radiation OncologyBiologyPhysics OncologyRadiation TherapyLate Toxicity ComparedNrg Oncology-rtog 1203Cancer Treatment	2019	15
Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy Karen M. Gil, Stephanie L. Pugh, Ann H. Klopp, Gynecologic Oncology UrologyUrinary DomainsGenitourinary CancerMedicineEpic Bowel	2019	14
Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis Jelle Koopsen, Gail Matthews, Juergen Rockstroh, The Lancet Microbe	2023	10
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial Jyoti Mayadev, Dmitriy Zamarin, Wei Deng, Nature Communications	2025	10

Page 1